| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.877 | 0.004 | 0.946 | Aldehyde oxidase inhibitor | 0.682 0.01 DBMET02793 0.946 0.003 DBMET02794 0.684 0.009 DBMET02795 | DBMET02794 | |
| 0.467 | 0.042 | 0.467 | Histamine release inhibitor | 0.25 0.155 DBMET02793 0.463 0.044 DBMET02794 0.278 0.136 DBMET02795 | ||
| 0.394 | 0.005 | 0.516 | Histamine H1 receptor antagonist | 0.164 0.021 DBMET02793 0.273 0.008 DBMET02794 0.516 0.004 DBMET02795 | DBMET02795 | |
| 0.361 | 0.012 | 0.451 | 5 Hydroxytryptamine 2 antagonist | 0.451 0.008 DBMET02793 0.284 0.018 DBMET02794 0.09 0.08 DBMET02795 | DBMET02793 | |
| 0.364 | 0.049 | 0.37 | Vasodilator, coronary | 0.269 0.116 DBMET02793 0.37 0.046 DBMET02794 0.206 0.177 DBMET02795 | DBMET02794 | |
| 0.305 | 0.005 | 0.605 | 5 Hydroxytryptamine 1F antagonist | 0.605 0.004 DBMET02793 0.217 0.009 DBMET02794 0.113 0.026 DBMET02795 | DBMET02793 | |
| 0.368 | 0.079 | 0.454 | MAP kinase kinase 6 inhibitor | 0.454 0.033 DBMET02793 0.312 0.124 DBMET02794 0.287 0.149 DBMET02795 | DBMET02793 | |
| 0.343 | 0.055 | 0.343 | Spasmolytic | 0.326 0.061 DBMET02794 | ||
| 0.319 | 0.035 | 0.349 | Cyclic AMP phosphodiesterase inhibitor | 0.349 0.026 DBMET02793 0.349 0.026 DBMET02794 | DBMET02794 | |
| 0.286 | 0.008 | 0.418 | Mediator release inhibitor | 0.09 0.081 DBMET02793 0.406 0.005 DBMET02794 0.418 0.005 DBMET02795 | DBMET02795 | |
| 0.393 | 0.115 | 0.54 | Caspase 9 stimulant | 0.54 0.047 DBMET02793 0.479 0.068 DBMET02794 | DBMET02793 | |
| 0.289 | 0.012 | 0.404 | 5 Hydroxytryptamine 2A antagonist | 0.404 0.007 DBMET02793 0.199 0.02 DBMET02794 | DBMET02793 | |
| 0.257 | 0.007 | 0.32 | Dopamine D1 antagonist | 0.216 0.01 DBMET02793 0.32 0.005 DBMET02794 0.063 0.046 DBMET02795 | DBMET02794 | |
| 0.269 | 0.021 | 0.269 | Acetylcholine M1 receptor antagonist | 0.212 0.037 DBMET02793 0.231 0.031 DBMET02794 0.143 0.081 DBMET02795 | ||
| 0.258 | 0.017 | 0.296 | Antiadrenergic | 0.296 0.014 DBMET02793 0.212 0.022 DBMET02794 0.099 0.056 DBMET02795 | DBMET02793 | |
| 0.256 | 0.017 | 0.293 | Adrenaline antagonist | 0.293 0.014 DBMET02793 0.209 0.022 DBMET02794 0.097 0.055 DBMET02795 | DBMET02793 | |
| 0.251 | 0.013 | 0.255 | Dopamine D2 antagonist | 0.237 0.014 DBMET02793 0.234 0.014 DBMET02794 0.255 0.013 DBMET02795 | DBMET02795 | |
| 0.25 | 0.014 | 0.341 | Antihistaminic | 0.148 0.033 DBMET02793 0.131 0.038 DBMET02794 0.341 0.008 DBMET02795 | DBMET02795 | |
| 0.245 | 0.019 | 0.389 | 5 Hydroxytryptamine 2B antagonist | 0.389 0.009 DBMET02793 0.215 0.024 DBMET02794 | DBMET02793 | |
| 0.238 | 0.015 | 0.257 | Dopamine antagonist | 0.257 0.014 DBMET02793 0.222 0.017 DBMET02794 0.211 0.018 DBMET02795 | DBMET02793 | |
| 0.242 | 0.026 | 0.4 | 5 Hydroxytryptamine antagonist | 0.4 0.011 DBMET02793 0.163 0.044 DBMET02794 | DBMET02793 | |
| 0.228 | 0.015 | 0.285 | Histamine antagonist | 0.139 0.032 DBMET02793 0.111 0.042 DBMET02794 0.285 0.01 DBMET02795 | DBMET02795 | |
| 0.232 | 0.022 | 0.285 | Alpha adrenoreceptor antagonist | 0.285 0.017 DBMET02793 0.198 0.028 DBMET02794 | DBMET02793 | |
| 0.352 | 0.149 | 0.452 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.452 0.06 DBMET02793 0.296 0.218 DBMET02795 | DBMET02793 | |
| 0.208 | 0.009 | 0.208 | Multidrug resistance-associated protein 1 inhibitor | 0.2 0.01 DBMET02794 0.172 0.017 DBMET02795 | ||
| 0.249 | 0.054 | 0.267 | MAP kinase kinase 2 inhibitor | 0.267 0.047 DBMET02793 0.194 0.085 DBMET02794 | DBMET02793 | |
| 0.204 | 0.017 | 0.36 | 5 Hydroxytryptamine 2C antagonist | 0.36 0.007 DBMET02793 0.147 0.027 DBMET02794 | DBMET02793 | |
| 0.215 | 0.03 | 0.344 | Toll-Like receptor 9 antagonist | 0.344 0.007 DBMET02793 0.208 0.032 DBMET02794 0.335 0.008 DBMET02795 | DBMET02793 | |
| 0.288 | 0.103 | 0.288 | Vasodilator, peripheral | 0.288 0.103 DBMET02794 0.27 0.114 DBMET02795 | ||
| 0.193 | 0.025 | 0.33 | Alpha 2b adrenoreceptor antagonist | 0.33 0.007 DBMET02793 0.179 0.029 DBMET02794 | DBMET02793 | |
| 0.18 | 0.024 | 0.21 | Alpha 1 adrenoreceptor antagonist | 0.21 0.019 DBMET02793 0.146 0.03 DBMET02794 | DBMET02793 | |
| 0.183 | 0.031 | 0.183 | Nav1.3 sodium channel blocker | 0.104 0.093 DBMET02793 0.12 0.074 DBMET02794 | ||
| 0.163 | 0.019 | 0.208 | Alpha 1b adrenoreceptor antagonist | 0.208 0.014 DBMET02793 0.144 0.023 DBMET02794 | DBMET02793 | |
| 0.312 | 0.168 | 0.312 | MAP kinase 1 inhibitor | 0.279 0.204 DBMET02794 | ||
| 0.233 | 0.09 | 0.353 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.353 0.011 DBMET02793 0.205 0.152 DBMET02794 | DBMET02793 | |
| 0.22 | 0.081 | 0.234 | Potassium channel blocker | 0.234 0.074 DBMET02793 0.234 0.074 DBMET02795 | DBMET02795 | |
| 0.143 | 0.005 | 0.282 | 5 Hydroxytryptamine 3 agonist | 0.282 0.003 DBMET02793 0.114 0.01 DBMET02794 0.077 0.029 DBMET02795 | DBMET02793 | |
| 0.17 | 0.033 | 0.17 | Antibacterial (Helicobacter pylori) | 0.11 0.098 DBMET02793 0.144 0.051 DBMET02794 0.108 0.103 DBMET02795 | ||
| 0.163 | 0.027 | 0.214 | Alpha 2c adrenoreceptor antagonist | 0.214 0.015 DBMET02793 0.152 0.031 DBMET02794 | DBMET02793 | |
| 0.154 | 0.018 | 0.264 | 5 Hydroxytryptamine 7 antagonist | 0.264 0.007 DBMET02793 0.084 0.03 DBMET02794 0.054 0.05 DBMET02795 | DBMET02793 | |
| 0.261 | 0.134 | 0.325 | Calcium channel activator | 0.325 0.069 DBMET02793 0.276 0.118 DBMET02794 | DBMET02793 | |
| 0.183 | 0.062 | 0.241 | Antipruritic | 0.136 0.112 DBMET02794 0.241 0.027 DBMET02795 | DBMET02795 | |
| 0.124 | 0.005 | 0.163 | Potassium channel (Inward rectifier) blocker | 0.051 0.033 DBMET02793 0.08 0.012 DBMET02794 0.163 0.004 DBMET02795 | DBMET02795 | |
| 0.141 | 0.025 | 0.18 | Alpha 1a adrenoreceptor antagonist | 0.18 0.019 DBMET02793 0.115 0.031 DBMET02794 | DBMET02793 | |
| 0.155 | 0.041 | 0.155 | Acetylcholine muscarinic antagonist | 0.12 0.067 DBMET02793 0.131 0.057 DBMET02794 | ||
| 0.197 | 0.085 | 0.292 | Anticonvulsant | 0.146 0.134 DBMET02793 0.15 0.129 DBMET02794 0.292 0.043 DBMET02795 | DBMET02795 | |
| 0.159 | 0.048 | 0.162 | MAP3K9 inhibitor | 0.162 0.044 DBMET02793 0.148 0.063 DBMET02794 | DBMET02793 | |
| 0.159 | 0.049 | 0.252 | NADPH oxidase inhibitor | 0.237 0.024 DBMET02793 0.252 0.02 DBMET02794 | DBMET02794 | |
| 0.128 | 0.018 | 0.163 | Alpha 1d adrenoreceptor antagonist | 0.163 0.013 DBMET02793 0.098 0.024 DBMET02794 | DBMET02793 | |
| 0.14 | 0.03 | 0.295 | Alpha 2 adrenoreceptor antagonist | 0.295 0.008 DBMET02793 0.13 0.033 DBMET02794 | DBMET02793 | |
| 0.146 | 0.038 | 0.146 | GABA receptor agonist | 0.11 0.066 DBMET02793 0.093 0.085 DBMET02794 0.145 0.039 DBMET02795 | ||
| 0.183 | 0.077 | 0.183 | P-glycoprotein inhibitor | 0.177 0.082 DBMET02794 0.18 0.08 DBMET02795 | ||
| 0.123 | 0.017 | 0.146 | Acetylcholine M4 receptor antagonist | 0.146 0.011 DBMET02793 0.076 0.05 DBMET02794 0.068 0.06 DBMET02795 | DBMET02793 | |
| 0.11 | 0.007 | 0.119 | Glucosylceramidase inhibitor | 0.119 0.005 DBMET02793 0.08 0.015 DBMET02794 0.076 0.018 DBMET02795 | DBMET02793 | |
| 0.164 | 0.063 | 0.225 | Hexokinase inhibitor | 0.225 0.023 DBMET02793 0.178 0.05 DBMET02794 | DBMET02793 | |
| 0.194 | 0.094 | 0.325 | HERG channel blocker | 0.325 0.043 DBMET02793 0.151 0.13 DBMET02795 | DBMET02793 | |
| 0.134 | 0.034 | 0.134 | Gastric antisecretory | 0.088 0.081 DBMET02793 0.098 0.069 DBMET02794 0.103 0.063 DBMET02795 | ||
| 0.147 | 0.05 | 0.147 | Anesthetic local | 0.108 0.076 DBMET02794 | ||
| 0.13 | 0.034 | 0.13 | Acetylcholine release stimulant | 0.125 0.041 DBMET02793 0.101 0.086 DBMET02794 | ||
| 0.106 | 0.014 | 0.345 | 5 Hydroxytryptamine 1A agonist | 0.345 0.005 DBMET02793 0.068 0.023 DBMET02794 0.042 0.035 DBMET02795 | DBMET02793 | |
| 0.131 | 0.041 | 0.209 | Sphingosine 1-phosphate receptor 2 agonist | 0.209 0.01 DBMET02793 0.12 0.055 DBMET02794 | DBMET02793 | |
| 0.124 | 0.039 | 0.355 | Protein kinase C mu inhibitor | 0.355 0.004 DBMET02793 0.102 0.055 DBMET02794 | DBMET02793 | |
| 0.116 | 0.033 | 0.116 | mTOR complex 1 inhibitor | 0.103 0.057 DBMET02794 0.105 0.051 DBMET02795 | ||
| 0.18 | 0.097 | 0.18 | Platelet aggregation inhibitor | 0.152 0.126 DBMET02794 | ||
| 0.11 | 0.03 | 0.11 | GABA A receptor agonist | 0.091 0.047 DBMET02793 0.076 0.071 DBMET02794 0.105 0.034 DBMET02795 | ||
| 0.109 | 0.032 | 0.285 | Alpha 2a adrenoreceptor antagonist | 0.285 0.007 DBMET02793 0.118 0.029 DBMET02794 | DBMET02793 | |
| 0.105 | 0.03 | 0.19 | 5 Hydroxytryptamine 1A antagonist | 0.19 0.016 DBMET02793 0.086 0.037 DBMET02794 | DBMET02793 | |
| 0.101 | 0.026 | 0.128 | Dopamine D4 antagonist | 0.128 0.02 DBMET02793 0.088 0.03 DBMET02794 | DBMET02793 | |
| 0.141 | 0.068 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.137 0.087 DBMET02793 0.131 0.113 DBMET02794 | ||
| 0.13 | 0.059 | 0.13 | Adenylate cyclase inhibitor | 0.117 0.07 DBMET02794 | ||
| 0.21 | 0.141 | 0.356 | Hypoxia-inducible factor 1 alpha inhibitor | 0.356 0.043 DBMET02793 0.256 0.095 DBMET02794 | DBMET02793 | |
| 0.075 | 0.006 | 0.1 | Acetylcholine M4 receptor agonist | 0.1 0.004 DBMET02793 | DBMET02793 | |
| 0.14 | 0.073 | 0.257 | Ribosomal protein S6 kinase inhibitor | 0.257 0.019 DBMET02793 0.109 0.104 DBMET02794 | DBMET02793 | |
| 0.131 | 0.064 | 0.131 | Cholinergic antagonist | 0.122 0.071 DBMET02793 0.106 0.088 DBMET02794 | ||
| 0.086 | 0.022 | 0.128 | Protein kinase C beta inhibitor | 0.128 0.005 DBMET02793 0.079 0.031 DBMET02794 | DBMET02793 | |
| 0.093 | 0.03 | 0.093 | Phosphodiesterase 5A inhibitor | 0.081 0.039 DBMET02794 0.066 0.055 DBMET02795 | ||
| 0.084 | 0.022 | 0.084 | Acetylcholine M5 receptor antagonist | 0.071 0.03 DBMET02793 0.063 0.038 DBMET02794 | ||
| 0.098 | 0.038 | 0.208 | 5 Hydroxytryptamine 1 antagonist | 0.208 0.016 DBMET02793 0.074 0.05 DBMET02794 | DBMET02793 | |
| 0.176 | 0.117 | 0.208 | 5 Hydroxytryptamine 3E antagonist | 0.208 0.051 DBMET02793 0.163 0.159 DBMET02795 | DBMET02793 | |
| 0.09 | 0.033 | 0.09 | Phosphodiesterase V inhibitor | 0.079 0.042 DBMET02794 0.064 0.058 DBMET02795 | ||
| 0.124 | 0.067 | 0.124 | Acetylcholine antagonist | 0.118 0.072 DBMET02793 0.102 0.09 DBMET02794 | ||
| 0.167 | 0.11 | 0.167 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.145 0.142 DBMET02793 0.158 0.121 DBMET02794 | ||
| 0.07 | 0.015 | 0.07 | Purinergic P2Y antagonist | 0.062 0.018 DBMET02794 | ||
| 0.084 | 0.035 | 0.084 | Phosphodiesterase VI inhibitor | 0.075 0.051 DBMET02794 0.077 0.046 DBMET02795 | ||
| 0.116 | 0.068 | 0.157 | Transcription factor STAT6 inhibitor | 0.157 0.018 DBMET02793 0.111 0.078 DBMET02794 | DBMET02793 | |
| 0.113 | 0.067 | 0.113 | Photosensitizer | 0.104 0.082 DBMET02793 0.099 0.09 DBMET02794 | ||
| 0.06 | 0.015 | 0.067 | DNA-dependent protein kinase inhibitor | 0.067 0.012 DBMET02793 0.065 0.013 DBMET02794 | DBMET02793 | |
| 0.066 | 0.022 | 0.067 | Acetylcholine M2 receptor agonist | 0.067 0.022 DBMET02793 0.053 0.038 DBMET02794 | DBMET02793 | |
| 0.054 | 0.011 | 0.054 | DNA gyrase subunit B inhibitor | 0.051 0.012 DBMET02793 | ||
| 0.167 | 0.124 | 0.272 | Potassium channel (Voltage-sensitive) blocker | 0.272 0.058 DBMET02793 | DBMET02793 | |
| 0.209 | 0.167 | 0.209 | Antithrombotic | |||
| 0.072 | 0.032 | 0.072 | Interferon inducer | 0.061 0.052 DBMET02795 | ||
| 0.085 | 0.045 | 0.085 | Interferon agonist | |||
| 0.074 | 0.035 | 0.126 | Dopamine D3 antagonist | 0.126 0.019 DBMET02793 0.058 0.047 DBMET02794 | DBMET02793 | |
| 0.077 | 0.039 | 0.089 | Phospholipase D inhibitor | 0.089 0.023 DBMET02793 | DBMET02793 | |
| 0.095 | 0.057 | 0.253 | Protein kinase C zeta inhibitor | 0.253 0.007 DBMET02793 0.101 0.05 DBMET02794 | DBMET02793 | |
| 0.12 | 0.084 | 0.228 | Toll-Like receptor antagonist | 0.156 0.051 DBMET02793 0.118 0.087 DBMET02794 0.228 0.022 DBMET02795 | DBMET02795 | |
| 0.046 | 0.011 | 0.062 | ATM kinase inhibitor | 0.062 0.005 DBMET02793 0.041 0.016 DBMET02794 | DBMET02793 | |
| 0.109 | 0.077 | 0.199 | Estrogen antagonist | 0.199 0.013 DBMET02794 | DBMET02794 | |
| 0.068 | 0.038 | 0.088 | DNA gyrase inhibitor | 0.088 0.022 DBMET02793 | DBMET02793 | |
| 0.088 | 0.057 | 0.155 | Acetylcholine agonist | 0.155 0.024 DBMET02793 | DBMET02793 | |
| 0.081 | 0.05 | 0.157 | Macrophage migration inhibitory factor inhibitor | 0.157 0.013 DBMET02794 | DBMET02794 | |
| 0.059 | 0.031 | 0.1 | Myc inhibitor | 0.1 0.008 DBMET02793 | DBMET02793 | |
| 0.083 | 0.055 | 0.102 | Caspase 7 inhibitor | 0.102 0.027 DBMET02793 | DBMET02793 | |
| 0.074 | 0.047 | 0.074 | Calcium channel L-type blocker | |||
| 0.036 | 0.01 | 0.037 | Potassium channel (Inward rectifier) 1 blocker | 0.03 0.022 DBMET02794 0.037 0.009 DBMET02795 | DBMET02795 | |
| 0.058 | 0.033 | 0.208 | 5 Hydroxytryptamine 1 agonist | 0.208 0.01 DBMET02793 | DBMET02793 | |
| 0.066 | 0.042 | 0.106 | 5 Hydroxytryptamine uptake inhibitor | 0.106 0.024 DBMET02793 | DBMET02793 | |
| 0.172 | 0.148 | 0.172 | RNA-directed DNA polymerase inhibitor | |||
| 0.083 | 0.061 | 0.083 | mTOR complex 2 inhibitor | |||
| 0.082 | 0.059 | 0.086 | Transforming growth factor beta 3 antagonist | 0.086 0.048 DBMET02793 | DBMET02793 | |
| 0.196 | 0.175 | 0.245 | Caspase 3 stimulant | 0.189 0.187 DBMET02793 0.245 0.116 DBMET02794 | DBMET02794 | |
| 0.095 | 0.074 | 0.175 | Estrogen receptor beta antagonist | 0.175 0.012 DBMET02794 | DBMET02794 | |
| 0.063 | 0.042 | 0.063 | Acetylcholine M2 receptor antagonist | 0.053 0.051 DBMET02793 | ||
| 0.097 | 0.077 | 0.11 | DNA intercalator | 0.11 0.064 DBMET02794 | DBMET02794 | |
| 0.027 | 0.01 | 0.027 | Phosphodiesterase 6A inhibitor | 0.023 0.016 DBMET02794 0.025 0.012 DBMET02795 | ||
| 0.095 | 0.078 | 0.149 | Beta glucuronidase inhibitor | 0.149 0.025 DBMET02793 0.112 0.054 DBMET02794 | DBMET02793 | |
| 0.048 | 0.033 | 0.048 | Cytokine production stimulant | |||
| 0.064 | 0.051 | 0.405 | 5 Hydroxytryptamine agonist | 0.405 0.005 DBMET02793 | DBMET02793 | |
| 0.146 | 0.133 | 0.231 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.231 0.058 DBMET02793 | DBMET02793 | |
| 0.063 | 0.051 | 0.063 | Acetylcholine M5 receptor agonist | |||
| 0.049 | 0.038 | 0.087 | H+/K+-transporting ATPase inhibitor | 0.087 0.011 DBMET02795 | DBMET02795 | |
| 0.049 | 0.039 | 0.056 | mTOR inhibitor | 0.056 0.032 DBMET02793 | DBMET02793 | |
| 0.098 | 0.088 | 0.137 | Topoisomerase II inhibitor | 0.102 0.084 DBMET02793 0.137 0.056 DBMET02794 | DBMET02794 | |
| 0.186 | 0.178 | 0.243 | Cholesterol antagonist | 0.243 0.13 DBMET02794 | DBMET02794 | |
| 0.102 | 0.093 | 0.102 | MAP kinase kinase inhibitor | |||
| 0.064 | 0.055 | 0.122 | Protein kinase B alpha inhibitor | 0.122 0.017 DBMET02793 | DBMET02793 | |
| 0.076 | 0.068 | 0.076 | Calcium antagonist | |||
| 0.052 | 0.045 | 0.171 | 5 Hydroxytryptamine 6 antagonist | 0.171 0.005 DBMET02793 | DBMET02793 | |
| 0.085 | 0.079 | 0.085 | MAP kinase kinase 1 inhibitor | |||
| 0.039 | 0.033 | 0.042 | Dopamine D5 antagonist | 0.042 0.031 DBMET02794 | DBMET02794 | |
| 0.053 | 0.048 | 0.183 | Protein kinase C iota inhibitor | 0.183 0.005 DBMET02793 | DBMET02793 | |
| 0.039 | 0.035 | 0.047 | Dopamine D2 agonist | 0.047 0.029 DBMET02794 0.041 0.034 DBMET02795 | DBMET02794 | |
| 0.029 | 0.027 | 0.055 | LIM domain kinase 2 inhibitor | 0.055 0.005 DBMET02793 | DBMET02793 | |
| 0.058 | 0.058 | 0.17 | 5 Hydroxytryptamine 3A antagonist | 0.17 0.004 DBMET02793 | DBMET02793 | |
| 0.035 | 0.035 | 0.044 | MAP3K5 inhibitor | 0.044 0.019 DBMET02793 | DBMET02793 | |
| 0.043 | 0.044 | 0.066 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.066 0.027 DBMET02793 | DBMET02793 | |
| 0.038 | 0.04 | 0.04 | Phosphodiesterase 3B inhibitor | 0.04 0.037 DBMET02794 | DBMET02794 | |
| 0.056 | 0.06 | 0.191 | Alpha adrenoreceptor agonist | 0.191 0.009 DBMET02793 | DBMET02793 | |
| 0.084 | 0.088 | 0.095 | Insulin receptor antagonist | 0.095 0.069 DBMET02793 | DBMET02793 | |
| 0.053 | 0.059 | 0.066 | Dopamine agonist | 0.066 0.047 DBMET02794 | DBMET02794 | |
| 0.046 | 0.051 | 0.077 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.077 0.018 DBMET02794 | DBMET02794 | |
| 0.045 | 0.05 | 0.057 | Acetylcholine muscarinic agonist | 0.057 0.036 DBMET02793 | DBMET02793 | |
| 0.083 | 0.09 | 0.095 | Interleukin 12 antagonist | 0.095 0.063 DBMET02794 | DBMET02794 | |
| 0.09 | 0.099 | 0.104 | c-Src kinase inhibitor | 0.104 0.087 DBMET02793 | DBMET02793 | |
| 0.087 | 0.097 | 0.112 | Chelator | 0.112 0.062 DBMET02794 | DBMET02794 | |
| 0.045 | 0.056 | 0.236 | 5 Hydroxytryptamine 3 antagonist | 0.236 0.005 DBMET02793 | DBMET02793 | |
| 0.154 | 0.166 | 0.236 | DNA damaging | 0.173 0.142 DBMET02793 0.236 0.089 DBMET02795 | DBMET02795 | |
| 0.093 | 0.104 | 0.101 | CDK3/cyclin E inhibitor | 0.101 0.086 DBMET02793 | DBMET02793 | |
| 0.046 | 0.059 | 0.151 | Alpha 1 adrenoreceptor agonist | 0.151 0.009 DBMET02793 | DBMET02793 | |
| 0.082 | 0.095 | 0.094 | Nav1.1 sodium channel blocker | 0.094 0.074 DBMET02794 | DBMET02794 | |
| 0.058 | 0.072 | 0.064 | Histone deacetylase SIRT1 stimulant | 0.064 0.062 DBMET02794 | DBMET02794 | |
| 0.058 | 0.072 | 0.064 | Histone deacetylase stimulant | 0.064 0.062 DBMET02794 | DBMET02794 | |
| 0.054 | 0.069 | 0.066 | Lipase inhibitor | 0.066 0.058 DBMET02794 | DBMET02794 | |
| 0.12 | 0.136 | 0.314 | LIM domain kinase 1 inhibitor | 0.314 0.018 DBMET02793 | DBMET02793 | |
| 0.01 | 0.028 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DBMET02793 | DBMET02793 | |
| 0.045 | 0.064 | 0.084 | Cyclin-dependent kinase 6 inhibitor | 0.084 0.019 DBMET02793 | DBMET02793 | |
| 0.027 | 0.047 | 0.044 | Cyclin D3 inhibitor | 0.044 0.024 DBMET02793 | DBMET02793 | |
| 0.095 | 0.117 | 0.133 | Cytokine production inhibitor | 0.133 0.077 DBMET02793 | DBMET02793 | |
| 0.048 | 0.071 | 0.184 | 5 Hydroxytryptamine 1B antagonist | 0.184 0.009 DBMET02793 | DBMET02793 | |
| 0.067 | 0.091 | 0.083 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.083 0.059 DBMET02794 | DBMET02794 | |
| 0.063 | 0.089 | 0.097 | Estrogen receptor alpha antagonist | 0.097 0.029 DBMET02794 | DBMET02794 | |
| 0.156 | 0.183 | 0.318 | 5 Hydroxytryptamine 1E antagonist | 0.318 0.02 DBMET02793 | DBMET02793 | |
| 0.04 | 0.066 | 0.093 | Protein kinase C eta inhibitor | 0.093 0.019 DBMET02793 | DBMET02793 | |
| 0.044 | 0.07 | 0.083 | Phosphodiesterase VII inhibitor | 0.083 0.023 DBMET02793 | DBMET02793 | |
| 0.02 | 0.047 | 0.064 | Myristoyl transferase inhibitor | 0.064 0.004 DBMET02793 | DBMET02793 | |
| 0.023 | 0.051 | 0.088 | 5 Hydroxytryptamine 3B antagonist | 0.088 0.006 DBMET02793 | DBMET02793 | |
| 0.083 | 0.111 | 0.19 | Protein kinase C gamma inhibitor | 0.19 0.016 DBMET02793 | DBMET02793 | |
| 0.011 | 0.042 | 0.029 | Adenosine kinase inhibitor | 0.029 0.01 DBMET02793 | DBMET02793 | |
| 0.042 | 0.073 | 0.064 | Phosphatidylinositol kinase inhibitor | 0.064 0.038 DBMET02793 | DBMET02793 | |
| 0.07 | 0.102 | 0.11 | Topoisomerase I inhibitor | 0.11 0.062 DBMET02794 0.094 0.075 DBMET02795 | DBMET02794 | |
| 0.036 | 0.07 | 0.095 | Histamine H4 receptor antagonist | 0.095 0.005 DBMET02793 | DBMET02793 | |
| 0.018 | 0.053 | 0.053 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.037 0.023 DBMET02793 0.053 0.014 DBMET02794 | DBMET02794 | |
| 0.068 | 0.104 | 0.087 | Breast cancer-resistant protein inhibitor | 0.087 0.07 DBMET02794 | DBMET02794 | |
| 0.054 | 0.091 | 0.096 | Protein kinase B gamma inhibitor | 0.096 0.034 DBMET02793 | DBMET02793 | |
| 0.024 | 0.06 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.018 DBMET02794 | DBMET02794 | |
| 0.167 | 0.204 | 0.381 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.381 0.026 DBMET02793 | DBMET02793 | |
| 0.111 | 0.149 | 0.155 | Adenylate cyclase stimulant | 0.155 0.055 DBMET02793 | DBMET02793 | |
| 0.034 | 0.072 | 0.054 | Phosphatidylinositol 3-kinase beta inhibitor | 0.054 0.029 DBMET02793 | DBMET02793 | |
| 0.026 | 0.065 | 0.042 | Acetylcholine M1 receptor agonist | 0.042 0.03 DBMET02793 | DBMET02793 | |
| 0.12 | 0.16 | 0.243 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.243 0.059 DBMET02793 | DBMET02793 | |
| 0.128 | 0.169 | 0.155 | Catenin beta inhibitor | 0.155 0.095 DBMET02794 | DBMET02794 | |
| 0.074 | 0.116 | 0.1 | Glutamate release inhibitor | 0.1 0.043 DBMET02793 | DBMET02793 | |
| 0.046 | 0.089 | 0.119 | I kappa B kinase 2 inhibitor | 0.119 0.008 DBMET02793 | DBMET02793 | |
| 0.059 | 0.104 | 0.154 | I kappa B kinase inhibitor | 0.154 0.015 DBMET02793 | DBMET02793 | |
| 0.114 | 0.159 | 0.205 | Tumour necrosis factor antagonist | 0.205 0.051 DBMET02793 | DBMET02793 | |
| 0.051 | 0.097 | 0.075 | Fibroblast growth factor 3 antagonist | 0.075 0.057 DBMET02793 | DBMET02793 | |
| 0.085 | 0.131 | 0.243 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.243 0.033 DBMET02793 | DBMET02793 | |
| 0.134 | 0.181 | 0.159 | Vasodilator | 0.159 0.144 DBMET02794 | DBMET02794 | |
| 0.097 | 0.144 | 0.147 | DNA repair enzyme inhibitor | 0.147 0.034 DBMET02793 | DBMET02793 | |
| 0.078 | 0.126 | 0.15 | Amylase inhibitor | 0.15 0.064 DBMET02794 | DBMET02794 | |
| 0.145 | 0.194 | 0.286 | MAP-kinase-activated kinase 5 inhibitor | 0.286 0.038 DBMET02793 | DBMET02793 | |
| 0.065 | 0.114 | 0.091 | MAP kinase kinase kinase inhibitor | 0.091 0.076 DBMET02793 | DBMET02793 | |
| 0.03 | 0.082 | 0.084 | CDK4/cyclin D1 inhibitor | 0.084 0.022 DBMET02793 | DBMET02793 | |
| 0.118 | 0.173 | 0.244 | 3C-like protease (Human coronavirus) inhibitor | 0.244 0.03 DBMET02793 | DBMET02793 | |
| 0.067 | 0.124 | 0.084 | Polo-like kinase-1 inhibitor | 0.084 0.074 DBMET02793 | DBMET02793 | |
| 0.02 | 0.078 | 0.065 | Vascular adhesion protein 1 inhibitor | 0.065 0.007 DBMET02793 | DBMET02793 | |
| 0.087 | 0.146 | 0.166 | CDC-like kinase 1 inhibitor | 0.166 0.058 DBMET02793 0.12 0.095 DBMET02794 | DBMET02793 | |
| 0.02 | 0.08 | 0.032 | CDK6/cyclin D3 inhibitor | 0.032 0.026 DBMET02793 | DBMET02793 | |
| 0.057 | 0.118 | 0.087 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.087 0.06 DBMET02793 | DBMET02793 | |
| 0.083 | 0.145 | 0.136 | Nav1.6 sodium channel blocker | 0.136 0.072 DBMET02793 | DBMET02793 | |
| 0.029 | 0.094 | 0.068 | Cannabinoid CB1 receptor agonist | 0.068 0.036 DBMET02795 | DBMET02795 | |
| 0.062 | 0.126 | 0.098 | MAP kinase kinase 7 inhibitor | 0.098 0.015 DBMET02793 | DBMET02793 | |
| 0.029 | 0.098 | 0.07 | CDK4/cyclin D inhibitor | 0.07 0.027 DBMET02793 | DBMET02793 | |
| 0.09 | 0.16 | 0.183 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.183 0.072 DBMET02793 | DBMET02793 | |
| 0.041 | 0.113 | 0.08 | CDK2/cyclin E2 inhibitor | 0.08 0.039 DBMET02793 | DBMET02793 | |
| 0.035 | 0.107 | 0.114 | Cyclin-dependent kinase 4 inhibitor | 0.114 0.021 DBMET02793 | DBMET02793 | |
| 0.109 | 0.183 | 0.23 | I kappa B kinase epsilon inhibitor | 0.23 0.049 DBMET02793 | DBMET02793 | |
| 0.033 | 0.109 | 0.05 | Phosphodiesterase 7A inhibitor | 0.05 0.039 DBMET02793 | DBMET02793 | |
| 0.042 | 0.12 | 0.134 | Rho-associated kinase I inhibitor | 0.134 0.018 DBMET02793 | DBMET02793 | |
| 0.084 | 0.161 | 0.124 | Cytidine deaminase inhibitor | 0.124 0.096 DBMET02793 | DBMET02793 | |
| 0.029 | 0.107 | 0.067 | Protein kinase C theta inhibitor | 0.067 0.027 DBMET02793 | DBMET02793 | |
| 0.167 | 0.246 | 0.209 | MAP kinase kinase 3 inhibitor | 0.209 0.098 DBMET02793 | DBMET02793 | |
| 0.081 | 0.163 | 0.199 | Activin receptor-like kinase 2 inhibitor | 0.199 0.037 DBMET02793 | DBMET02793 | |
| 0.013 | 0.096 | 0.037 | CDK4/cyclin D3 inhibitor | 0.037 0.011 DBMET02793 | DBMET02793 | |
| 0.105 | 0.188 | 0.124 | MAP kinase 3 inhibitor | 0.124 0.122 DBMET02793 | DBMET02793 | |
| 0.055 | 0.139 | 0.162 | Protein kinase C delta inhibitor | 0.162 0.017 DBMET02793 | DBMET02793 | |
| 0.047 | 0.132 | 0.102 | Cyclin-dependent kinase 1 inhibitor | 0.102 0.065 DBMET02793 | DBMET02793 | |
| 0.11 | 0.196 | 0.138 | MAP kinase kinase 4 inhibitor | 0.138 0.088 DBMET02793 | DBMET02793 | |
| 0.033 | 0.122 | 0.086 | Adrenaline uptake inhibitor | 0.086 0.024 DBMET02793 | DBMET02793 | |
| 0.045 | 0.134 | 0.088 | Histone deacetylase SIRT3 inhibitor | 0.088 0.014 DBMET02793 | DBMET02793 | |
| 0.028 | 0.117 | 0.12 | Pim-2 kinase inhibitor | 0.12 0.011 DBMET02793 | DBMET02793 | |
| 0.081 | 0.171 | 0.167 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.167 0.061 DBMET02793 | DBMET02793 | |
| 0.028 | 0.12 | 0.084 | Nicotinic alpha7 receptor agonist | 0.084 0.016 DBMET02793 | DBMET02793 | |
| 0.087 | 0.179 | 0.173 | Amyloid beta aggregation inhibitor | 0.173 0.093 DBMET02794 | DBMET02794 | |
| 0.053 | 0.146 | 0.078 | Vanilloid 4 agonist | 0.078 0.045 DBMET02793 | DBMET02793 | |
| 0.04 | 0.134 | 0.075 | Protein kinase B beta inhibitor | 0.075 0.049 DBMET02793 | DBMET02793 | |
| 0.027 | 0.121 | 0.062 | Histamine agonist | 0.062 0.025 DBMET02793 | DBMET02793 | |
| 0.014 | 0.114 | 0.055 | 5 Hydroxytryptamine 6 agonist | 0.055 0.004 DBMET02793 | DBMET02793 | |
| 0.092 | 0.193 | 0.143 | Platelet adhesion inhibitor | 0.143 0.115 DBMET02794 | DBMET02794 | |
| 0.012 | 0.114 | 0.073 | Estrogen agonist | 0.073 0.025 DBMET02794 | DBMET02794 | |
| 0.093 | 0.195 | 0.132 | Neuropeptide Y1 antagonist | 0.132 0.096 DBMET02793 | DBMET02793 | |
| 0.011 | 0.116 | 0.072 | Potassium channel small-conductance Ca-activated activator | 0.072 0.006 DBMET02793 | DBMET02793 | |
| 0.037 | 0.145 | 0.06 | 5 Hydroxytryptamine 5A antagonist | 0.06 0.046 DBMET02793 | DBMET02793 | |
| 0.018 | 0.128 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.028 DBMET02795 | DBMET02795 | |
| 0.041 | 0.151 | 0.15 | Acetylcholine nicotinic agonist | 0.15 0.017 DBMET02793 | DBMET02793 | |
| 0.033 | 0.144 | 0.057 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.041 DBMET02793 | DBMET02793 | |
| 0.027 | 0.14 | 0.056 | Lysine-specific demethylase 1A inhibitor | 0.056 0.034 DBMET02793 | DBMET02793 | |
| 0.085 | 0.203 | 0.138 | Cyclin-dependent kinase 8 inhibitor | 0.138 0.092 DBMET02793 | DBMET02793 | |
| 0.096 | 0.216 | 0.14 | Sphingosine 1-phosphate receptor 5 antagonist | 0.14 0.079 DBMET02795 | DBMET02795 | |
| 0.047 | 0.169 | 0.177 | Protein kinase (CK1) delta inhibitor | 0.177 0.038 DBMET02793 | DBMET02793 | |
| 0.149 | 0.271 | 0.273 | 15-Lipoxygenase inhibitor | 0.273 0.148 DBMET02793 0.236 0.177 DBMET02794 | DBMET02793 | |
| 0.009 | 0.137 | 0.194 | 5 Hydroxytryptamine 2C agonist | 0.194 0.004 DBMET02793 | DBMET02793 | |
| 0.024 | 0.152 | 0.094 | 5 Hydroxytryptamine 2A agonist | 0.094 0.017 DBMET02793 | DBMET02793 | |
| 0.056 | 0.187 | 0.114 | Alkylator | 0.114 0.074 DBMET02795 | DBMET02795 | |
| 0.038 | 0.169 | 0.13 | Protein kinase (CK2) inhibitor | 0.13 0.043 DBMET02793 | DBMET02793 | |
| 0.113 | 0.245 | 0.201 | Prostaglandin dehydrogenase inhibitor | 0.201 0.156 DBMET02793 | DBMET02793 | |
| 0.023 | 0.157 | 0.06 | Transforming growth factor beta 1 antagonist | 0.06 0.026 DBMET02793 | DBMET02793 | |
| 0.019 | 0.156 | 0.042 | Protein kinase (CK2) beta inhibitor | 0.042 0.011 DBMET02793 | DBMET02793 | |
| 0.038 | 0.176 | 0.094 | I kappa B kinase 1 inhibitor | 0.094 0.026 DBMET02793 | DBMET02793 | |
| 0.017 | 0.156 | 0.067 | Glutamate (mGluR1) antagonist | 0.067 0.033 DBMET02793 | DBMET02793 | |
| 0.03 | 0.171 | 0.088 | Protein kinase C alpha inhibitor | 0.088 0.028 DBMET02793 | DBMET02793 | |
| 0.038 | 0.179 | 0.114 | Histamine N-methyltransferase inhibitor | 0.114 0.034 DBMET02793 | DBMET02793 | |
| 0.02 | 0.166 | 0.084 | 5 Hydroxytryptamine 1D antagonist | 0.084 0.029 DBMET02793 | DBMET02793 | |
| 0.017 | 0.163 | 0.133 | 5 Hydroxytryptamine 2 agonist | 0.133 0.005 DBMET02793 | DBMET02793 | |
| 0.007 | 0.154 | 0.031 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.031 0.017 DBMET02793 | DBMET02793 | |
| 0.023 | 0.17 | 0.098 | Alpha 2 adrenoreceptor agonist | 0.098 0.015 DBMET02793 | DBMET02793 | |
| 0.06 | 0.209 | 0.119 | Alpha 2d adrenoreceptor antagonist | 0.119 0.024 DBMET02793 | DBMET02793 | |
| 0.004 | 0.153 | 0.03 | Estrogen receptor alpha agonist | 0.03 0.026 DBMET02794 | DBMET02794 | |
| 0.019 | 0.169 | 0.096 | Nicotinic neuronal receptor agonist | 0.096 0.014 DBMET02793 | DBMET02793 | |
| 0.095 | 0.246 | 0.196 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.196 0.094 DBMET02793 | DBMET02793 | |
| 0.016 | 0.169 | 0.058 | Protein kinase (CK1) epsilon inhibitor | 0.058 0.009 DBMET02793 | DBMET02793 | |
| 0.04 | 0.194 | 0.158 | Pim-1 kinase inhibitor | 0.158 0.025 DBMET02793 | DBMET02793 | |
| 0.02 | 0.176 | 0.067 | Nicotinic receptor alpha7 subunit antagonist | 0.067 0.023 DBMET02793 | DBMET02793 | |
| 0.111 | 0.269 | 0.133 | Heat shock protein 70 antagonist | 0.133 0.105 DBMET02793 | DBMET02793 | |
| 0.137 | 0.3 | 0.223 | Tyrosine 3 hydroxylase inhibitor | 0.223 0.099 DBMET02793 | DBMET02793 | |
| 0.032 | 0.196 | 0.076 | CDK/cyclin complex inhibitor | 0.076 0.073 DBMET02793 | DBMET02793 | |
| 0.021 | 0.19 | 0.1 | CDC7 inhibitor | 0.1 0.024 DBMET02793 | DBMET02793 | |
| 0.04 | 0.21 | 0.103 | Aurora-B kinase inhibitor | 0.103 0.078 DBMET02793 | DBMET02793 | |
| 0.018 | 0.19 | 0.07 | 5 Hydroxytryptamine 2B agonist | 0.07 0.006 DBMET02793 | DBMET02793 | |
| 0.106 | 0.28 | 0.183 | Superoxide dismutase inhibitor | 0.183 0.138 DBMET02793 | DBMET02793 | |
| 0.018 | 0.194 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.024 DBMET02793 | DBMET02793 | |
| 0.041 | 0.218 | 0.123 | Glycogen synthase kinase-3 alpha inhibitor | 0.123 0.082 DBMET02793 | DBMET02793 | |
| 0.023 | 0.205 | 0.079 | Check point kinase 1 inhibitor | 0.079 0.039 DBMET02793 | DBMET02793 | |
| 0.056 | 0.238 | 0.184 | Protein kinase C nu inhibitor | 0.184 0.054 DBMET02793 | DBMET02793 | |
| 0.101 | 0.286 | 0.141 | Neurotensin receptor agonist | 0.141 0.125 DBMET02793 | DBMET02793 | |
| 0.089 | 0.275 | 0.145 | Death-associated protein kinase 1 inhibitor | 0.145 0.048 DBMET02793 | DBMET02793 | |
| 0.044 | 0.233 | 0.107 | Cyclin-dependent kinase inhibitor | 0.107 0.083 DBMET02793 | DBMET02793 | |
| 0.017 | 0.208 | 0.046 | Benzodiazepine antagonist | 0.046 0.037 DBMET02793 | DBMET02793 | |
| 0.034 | 0.226 | 0.059 | Ryanodine receptor antagonist | 0.059 0.041 DBMET02793 | DBMET02793 | |
| 0.064 | 0.256 | 0.193 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.193 0.097 DBMET02793 | DBMET02793 | |
| 0.039 | 0.231 | 0.177 | Protein kinase (CK1) inhibitor | 0.177 0.05 DBMET02793 | DBMET02793 | |
| 0.024 | 0.216 | 0.057 | Topoisomerase II beta inhibitor | 0.057 0.025 DBMET02793 | DBMET02793 | |
| 0.028 | 0.222 | 0.112 | MAP-kinase-activated kinase 2 inhibitor | 0.112 0.023 DBMET02793 | DBMET02793 | |
| 0.018 | 0.213 | 0.063 | Cyclin A2 inhibitor | 0.063 0.044 DBMET02793 | DBMET02793 | |
| 0.061 | 0.256 | 0.197 | Pyruvate kinase inhibitor | 0.197 0.082 DBMET02793 | DBMET02793 | |
| 0.022 | 0.217 | 0.094 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.094 0.039 DBMET02793 | DBMET02793 | |
| 0.03 | 0.227 | 0.097 | Protein kinase (CK2) alpha inhibitor | 0.097 0.079 DBMET02793 | DBMET02793 | |
| 0.033 | 0.232 | 0.121 | Pim-3 kinase inhibitor | 0.121 0.03 DBMET02793 | DBMET02793 | |
| 0.034 | 0.234 | 0.122 | MAP-kinase-activated kinase inhibitor | 0.122 0.024 DBMET02793 | DBMET02793 | |
| 0.024 | 0.224 | 0.085 | Rho-associated kinase inhibitor | 0.085 0.043 DBMET02793 | DBMET02793 | |
| 0.078 | 0.281 | 0.166 | Free radical scavenger | 0.166 0.128 DBMET02794 | DBMET02794 | |
| 0.05 | 0.258 | 0.173 | Clk dual-specificity kinase inhibitor | 0.173 0.096 DBMET02793 | DBMET02793 | |
| 0.028 | 0.236 | 0.049 | Alpha 1b adrenoreceptor agonist | 0.049 0.037 DBMET02793 | DBMET02793 | |
| 0.062 | 0.277 | 0.2 | Dyrk kinase inhibitor | 0.2 0.098 DBMET02793 | DBMET02793 | |
| 0.039 | 0.255 | 0.207 | 5 Hydroxytryptamine 3A agonist | 0.207 0.013 DBMET02793 | DBMET02793 | |
| 0.017 | 0.237 | 0.063 | Benzodiazepine agonist | 0.063 0.062 DBMET02793 | DBMET02793 | |
| 0.05 | 0.27 | 0.142 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.142 0.127 DBMET02793 | DBMET02793 | |
| 0.052 | 0.273 | 0.276 | Interleukin 1 antagonist | 0.276 0.014 DBMET02795 | DBMET02795 | |
| 0.125 | 0.345 | 0.35 | GABA C receptor rho-3 antagonist | 0.35 0.086 DBMET02793 | DBMET02793 | |
| 0.034 | 0.266 | 0.076 | Viral attachment inhibitor | 0.076 0.059 DBMET02795 | DBMET02795 | |
| 0.024 | 0.258 | 0.113 | Check point kinase 2 inhibitor | 0.113 0.054 DBMET02793 | DBMET02793 | |
| 0.014 | 0.251 | 0.052 | Cyclin A inhibitor | 0.052 0.051 DBMET02793 | DBMET02793 | |
| 0.055 | 0.292 | 0.118 | Histone deacetylase SIRT1 inhibitor | 0.118 0.093 DBMET02793 | DBMET02793 | |
| 0.044 | 0.283 | 0.129 | CDC-like kinase 4 inhibitor | 0.129 0.119 DBMET02793 | DBMET02793 | |
| 0.004 | 0.247 | 0.02 | Histamine H4 receptor agonist | 0.02 0.012 DBMET02793 | DBMET02793 | |
| 0.033 | 0.279 | 0.052 | Immunoglobulin Fc receptor antagonist | 0.052 0.048 DBMET02793 | DBMET02793 | |
| 0.025 | 0.276 | 0.08 | Potassium channel (Ca-activated) activator | 0.08 0.075 DBMET02793 | DBMET02793 | |
| 0.044 | 0.303 | 0.125 | Activin receptor-like kinase 4 inhibitor | 0.125 0.046 DBMET02793 | DBMET02793 | |
| 0.076 | 0.335 | 0.188 | Focal adhesion kinase 2 inhibitor | 0.188 0.08 DBMET02793 | DBMET02793 | |
| 0.017 | 0.279 | 0.064 | Leukotriene synthesis inhibitor | 0.064 0.05 DBMET02795 | DBMET02795 | |
| 0.025 | 0.291 | 0.062 | Corticotropin releasing factor 2 receptor antagonist | 0.062 0.043 DBMET02793 | DBMET02793 | |
| 0.042 | 0.31 | 0.175 | Aryl hydrocarbon receptor agonist | 0.175 0.117 DBMET02793 | DBMET02793 | |
| 0.017 | 0.294 | 0.06 | Histone deacetylase inhibitor | 0.06 0.055 DBMET02793 | DBMET02793 | |
| 0.067 | 0.346 | 0.215 | Beta lactamase inhibitor | 0.215 0.176 DBMET02795 | DBMET02795 | |
| 0.027 | 0.306 | 0.093 | Polo-like kinase-4 inhibitor | 0.093 0.085 DBMET02793 | DBMET02793 | |
| 0.012 | 0.295 | 0.05 | Histamine H1 receptor agonist | 0.05 0.018 DBMET02793 | DBMET02793 | |
| 0.07 | 0.365 | 0.187 | Thyroid hormone beta antagonist | 0.187 0.166 DBMET02795 | DBMET02795 | |
| 0.049 | 0.346 | 0.21 | Interleukin antagonist | 0.21 0.079 DBMET02795 | DBMET02795 | |
| 0.106 | 0.405 | 0.17 | Nitric-oxide synthase stimulant | 0.17 0.152 DBMET02793 | DBMET02793 | |
| 0.058 | 0.357 | 0.133 | GABA C receptor rho-2 antagonist | 0.133 0.099 DBMET02793 | DBMET02793 | |
| 0.051 | 0.353 | 0.167 | Death-associated protein kinase 3 inhibitor | 0.167 0.099 DBMET02793 | DBMET02793 | |
| 0.087 | 0.389 | 0.241 | 5 Hydroxytryptamine release stimulant | 0.241 0.094 DBMET02793 | DBMET02793 | |
| 0.02 | 0.349 | 0.058 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.058 0.048 DBMET02793 | DBMET02793 | |
| 0.011 | 0.344 | 0.058 | Cyclin A1 inhibitor | 0.058 0.042 DBMET02793 | DBMET02793 | |
| 0.016 | 0.352 | 0.074 | Protein kinase A inhibitor | 0.074 0.067 DBMET02793 | DBMET02793 | |
| 0.035 | 0.378 | 0.295 | Interleukin 1b antagonist | 0.295 0.009 DBMET02795 | DBMET02795 | |
| 0.014 | 0.375 | 0.066 | Purinergic P2X4 antagonist | 0.066 0.011 DBMET02793 | DBMET02793 | |
| 0.024 | 0.389 | 0.094 | GABA C receptor agonist | 0.094 0.074 DBMET02793 | DBMET02793 | |
| 0.01 | 0.386 | 0.065 | CC chemokine 5 receptor antagonist | 0.065 0.022 DBMET02795 | DBMET02795 | |
| 0.027 | 0.405 | 0.091 | GABA C receptor rho-1 antagonist | 0.091 0.077 DBMET02793 | DBMET02793 | |
| 0.006 | 0.392 | 0.048 | Alpha 1d adrenoreceptor agonist | 0.048 0.018 DBMET02793 | DBMET02793 | |
| 0.037 | 0.499 | 0.204 | Tumour necrosis factor alpha release inhibitor | 0.204 0.106 DBMET02795 | DBMET02795 | |
| 0.096 | 0.559 | 0.214 | 5 Hydroxytryptamine uptake stimulant | 0.214 0.126 DBMET02793 | DBMET02793 | |
| 0.003 | 0.466 | 0.021 | Imidazoline I1 receptor antagonist | 0.021 0.013 DBMET02793 | DBMET02793 | |
| 0.056 | 0.597 | 0.202 | Sodium/bile acid cotransporter inhibitor | 0.202 0.185 DBMET02794 | DBMET02794 | |
| 0.012 | 0.683 | 0.051 | Alpha 1L adrenoreceptor agonist | 0.051 0.015 DBMET02793 | DBMET02793 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |